J Tack Selected Research

tegaserod (Zelnorm)

2/2011	Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia.
7/2006	Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective.
12/2005	A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Tack Research Topics

Disease

38	Gastroesophageal Reflux (GERD) 01/2018 - 07/2000
24	Dyspepsia (Indigestion) 07/2018 - 01/2000
17	Heartburn (Pyrosis) 11/2016 - 11/2002
15	Constipation 04/2022 - 12/2005
13	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018 - 03/2003
11	Pain (Aches) 01/2018 - 02/2004
10	Gastroparesis 01/2018 - 07/2003
9	Abdominal Pain (Pain, Abdominal) 01/2017 - 06/2006
7	Obesity 12/2016 - 09/2009
7	Hypersensitivity (Allergy) 12/2014 - 02/2006
6	Inflammation (Inflammations) 02/2020 - 04/2006
5	Esophageal Achalasia (Megaesophagus) 09/2018 - 08/2001
5	Nausea 10/2014 - 07/2003
5	Esophagitis 11/2011 - 07/2000
4	Weight Loss (Weight Reduction) 12/2017 - 05/2013
4	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2016 - 04/2007
4	Opioid-Induced Constipation 12/2015 - 02/2011
4	Duodenogastric Reflux 06/2012 - 10/2003
3	Cough 01/2018 - 04/2005
3	Dumping Syndrome (Syndrome, Dumping) 01/2018 - 06/2014
3	Chronic Cough 01/2018 - 04/2005
3	Peptic Ulcer (Peptic Ulcers) 03/2014 - 03/2003
3	Vomiting 12/2013 - 07/2003
3	Ganglion Cysts (Ganglion) 03/2010 - 06/2003
3	Chest Pain (Chest Pains) 04/2009 - 02/2006
3	Bile Reflux 06/2004 - 12/2000
2	Flatulence 01/2018 - 10/2014
2	Body Weight (Weight, Body) 08/2011 - 01/2006
2	Visceral Pain 06/2011 - 03/2009
2	Barrett Esophagus (Barrett's Esophagus) 01/2009 - 06/2004
2	Migraine Disorders (Migraine) 01/2007 - 01/2000
1	Chagas Disease (American Trypanosomiasis) 09/2018
1	Neoplasms (Cancer) 09/2018
1	Muscle Cramp (Cramp) 01/2018
1	Fatigue 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2018
1	Eructation (Eructations) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2017

Drug/Important Bio-Agent (IBA)

40	AcidsIBA 01/2018 - 07/2000
14	Proton Pump InhibitorsIBA 01/2018 - 10/2003
8	Pharmaceutical PreparationsIBA 04/2016 - 01/2000
6	Z 338IBA 01/2018 - 09/2008
6	prucaloprideIBA 12/2017 - 03/2009
4	Serotonin (5 Hydroxytryptamine)IBA 04/2016 - 06/2006
4	GhrelinIBA 09/2013 - 11/2005
4	Sumatriptan (Imigran)FDA LinkGeneric 01/2007 - 01/2000
3	Botulinum Toxins (Botulinum Toxin)IBA 09/2018 - 08/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2011
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 06/2014
3	CarbohydratesIBA 01/2018 - 06/2011
3	Baclofen FDA LinkGeneric 08/2017 - 10/2003
3	5-HT4 Serotonin ReceptorsIBA 04/2016 - 02/2015
3	goblet cell silencer inhibitorIBA 04/2016 - 07/2003
3	revexeprideIBA 04/2016 - 02/2015
3	Opioid Analgesics (Opioids)IBA 12/2015 - 10/2008
3	tegaserod (Zelnorm)FDA Link 02/2011 - 12/2005
3	Pepsin A (Pepsin)IBA 05/2007 - 08/2005
3	Bile Acids and Salts (Bile Acids)IBA 09/2006 - 12/2000
2	Phenobarbital (Luminal)FDA Link 02/2020 - 01/2014
2	Sildenafil Citrate (Viagra)FDA Link 07/2018 - 08/2001
2	pasireotideIBA 01/2018 - 06/2014
2	Mirtazapine (Rexer)FDA LinkGeneric 12/2017 - 01/2014
2	Metabotropic Glutamate 5 ReceptorIBA 08/2017 - 04/2011
2	LaxativesIBA 12/2015 - 01/2013
2	naloxegolIBA 08/2015 - 10/2014
2	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2015 - 02/2011
2	Biomarkers (Surrogate Marker)IBA 12/2014 - 09/2003
2	linaclotideIBA 06/2013 - 01/2013
2	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2013 - 01/2013
2	Parasympatholytics (Antispasmodics)IBA 04/2013 - 07/2006
2	Ghrelin ReceptorsIBA 06/2011 - 11/2005
2	AntacidsIBA 04/2011 - 02/2008
2	itoprideIBA 01/2011 - 06/2008
2	CytokinesIBA 03/2010 - 04/2009
2	Capsaicin (Zostrix)FDA Link 10/2009 - 04/2007
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 07/2008 - 12/2006
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 11/2006 - 01/2006
2	CausticsIBA 09/2006 - 08/2005
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2006 - 02/2006
2	Citalopram FDA LinkGeneric 08/2006 - 02/2006
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 07/2006 - 02/2006
1	N- (3- fluorophenyl)- 1- ((4- (((3S)- 3- methyl- 1- piperazinyl)methyl)phenyl)acetyl)- 4- piperidinamineIBA 01/2018
1	Fructans (Levans)IBA 01/2018
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018
1	polyolIBA 01/2018
1	mavoglurantIBA 08/2017
1	ibodutantIBA 01/2017
1	Acarbose FDA LinkGeneric 01/2017
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 01/2017
1	IncretinsIBA 01/2017

Therapy/Procedure

25	Therapeutics 04/2022 - 07/2001
5	Drug Therapy (Chemotherapy) 10/2015 - 01/2007
2	Heller Myotomy 11/2017 - 06/2012
2	Fundoplication 12/2015 - 12/2011
2	Aftercare (After-Treatment) 05/2013 - 07/2007
1	Myotomy 09/2018
1	Bariatric Surgery 01/2017
1	Enteral Nutrition (Feeding, Tube) 01/2017
1	Diet Therapy (Therapy, Diet) 01/2017